SPIROCOR Coronary Outcome by Respiratory Stress Examination

NCT01053975 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2010-11-08

No results posted yet for this study

Summary

The purpose of this study is to validate the accuracy of the SPIROCOR System in indicating the presence of significant coronary artery disease (S-CAD), as defined in ACC/AHA Guidelines, in subjects with suspected S-CAD.

Conditions

  • Severe Coronary Artery Disease (S-CAD)

Sponsors & Collaborators

  • Spirocor

    lead INDUSTRY

Principal Investigators

  • William Weintraub, MD · Christiana Care Health Systems

  • Ron Waksman, MD · Medstar Health Research Institute

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053975 on ClinicalTrials.gov